Mesothelin-targeted intrapleural CAR-T cells have been evaluated -in combination with ICI- in 14 patients with malignant mesothelioma and non-small cell lung cancer (NSCLC), with promising results (2 CR, 5 PR, and 4 SD) (45). Here, MSLN is linked to non-small cell lung carcinoma.